ARCHIVES

Centocor Withdraws Yondelis After FDA Calls for New Study

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

White House names five to NCAB, reappoints Niederhuber as chairman.

June 25, 2004

Johnson, Katterhagen Applaud CCOP RFA But With It Had Money For More Cancer Control

July 30, 1982

Rauscher Labels With Congress, Says NCI Needs More Money

May 2, 1975

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014

DCCP Board Gives Concept Approval To RFA For Biochemical Epidemiolgy, New And Recompeting Contract Program

September 23, 1983

Conferees Stalled On Money Bill, Running Out Of Time

September 17, 1976